Want to join the conversation?
$CVS's 3Q15 earnings rose 37% to $1.11 per diluted share and net income rose 31% to $1.25Bil from a year ago, driven by solid revenue and operating profit growth across all of its businesses. The company's revenue climbed 10.3% YoverY to $38.64Bil. The YoverY growth was helped by 13.3% growth in its Pharmacy Services segment revenues.
Still in yesterday’s $PZZA shock. I thought everyone had more pizza this football season!!
$TSLA stock downgraded to sell from hold by brokerage firm CFRA Research. However, the firm lifted the price target by $35 to $240.
$LB shares have plummeted after a disappointing quarter.